Learning Objectives:
1. Discuss prevention and management of tumor lysis syndrome
2. Describe appropriate workup and initial management of suspected hypercalcemia of malignancy
3. Describe appropriate workup and initial management of neutropenic fever
Accreditation
Mayo Clinic College of Medicine and Science is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Summary
As a provider accredited by ACCME, Mayo Clinic College of Medicine and Science (Mayo Clinic School of CPD) must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentation.
Listed below are individuals with control of the content of this program who have disclosed…
No relevant financial relationship(s) with industry:
Planning Committee:
Dr. Jamie Newman – None
Dr. Neel Shah – None
Andy Herber PA-C – None
Kyle Satterblom, PA-C – None
Emily Sorensen, DNP, APRN, CNP – None
Abigail Meyers, PA-C – None
Elizabeth Nelson, APRN, CNP – None
Amy Van Hoof – None
PRESENTER - Amber Koehler, PA-C - None
References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
Amber Koehler, PA-C
- Rasburicase
- Venetoclax
- Cefepime

Facebook
X
LinkedIn
Forward